• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两例具有新型微乳头状组织学亚型的肺神经内分泌癌中六种核蛋白的综合基因谱分析。

Comprehensive genetic profiling of six pulmonary nuclear protein in testis carcinomas with a novel micropapillary histological subtype in two cases.

机构信息

Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.

Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.

出版信息

Hum Pathol. 2021 Sep;115:56-66. doi: 10.1016/j.humpath.2021.02.004. Epub 2021 Mar 10.

DOI:10.1016/j.humpath.2021.02.004
PMID:33713695
Abstract

Nuclear protein in testis (NUT) carcinoma (NC) is a rare and aggressive neoplasm associated with a rearrangement of the NUT gene on chromosome 15q14. To date, genomic alterations of NCs, especially those in the lung, are poorly understood. In this study, immunohistochemistry staining, fluorescence in situ hybridization, and two next-generation sequencing (NGS) panels of 56 and 701 genes were used to explore the clinical, pathological, and genetic profiling of pulmonary NCs. Six pulmonary NC cases were confirmed, with a mean age of 41 years (range: 22-69 years) and a median survival time of 6.5 months (range: 2-19 months). Morphologically, typical abrupt keratinization was observed in four of six cases (67%), and two patients presented a mixed pattern of classical squamous component and micropapillary adenocarcinoma morphology. We also identified a case with NUT gene amplification instead of rearrangement. Furthermore, NGS analysis demonstrated the following fusions: BRD4-NUTM1 (2/4 cases) and NSD3-NUTM1 (2/4 cases), and the analysis highlighted 53 gene mutations, including 50 (94.3%, 50/53) single-nucleotide variations (SNVs) and three (5.7%, 3/53) long insertions/deletions. SNVs of MUC16 were the most common and occurred in three cases (75%). Moreover, SNVs of EPHA8, FANCA, TRIO, and USP6 were detected in two of four cases (50%). These 53 mutated genes were involved in 13 functional pathways based on enrichment analysis, especially in the PI3K-Akt signaling pathway. Finally, none of the cases showed obvious copy number variations and had low tumor mutational burden and stable microsatellite sites.

摘要

睾丸核蛋白(NUT)癌(NC)是一种罕见且侵袭性的肿瘤,与 15q14 染色体上的 NUT 基因重排有关。迄今为止,NC 的基因组改变,尤其是肺部的改变,了解甚少。在这项研究中,使用免疫组织化学染色、荧光原位杂交和两个下一代测序(NGS)面板(56 个和 701 个基因)来探索肺 NC 的临床、病理和遗传特征。共确诊了 6 例肺 NC 病例,平均年龄为 41 岁(范围:22-69 岁),中位生存时间为 6.5 个月(范围:2-19 个月)。形态学上,6 例中有 4 例(67%)观察到典型的突然角化,2 例患者表现为经典鳞状成分和微乳头状腺癌形态的混合模式。我们还发现了 1 例存在 NUT 基因扩增而不是重排的病例。此外,NGS 分析显示以下融合:BRD4-NUTM1(4 例中有 2 例)和 NSD3-NUTM1(4 例中有 2 例),分析突出了 53 个基因突变,包括 50 个(94.3%,50/53)单核苷酸变异(SNVs)和 3 个(5.7%,3/53)长插入/缺失。MUC16 的 SNVs 最常见,发生在 3 例中(75%)。此外,4 例中有 2 例(50%)检测到 EPHA8、FANCA、TRIO 和 USP6 的 SNVs。基于富集分析,这些 53 个突变基因涉及 13 个功能途径,特别是在 PI3K-Akt 信号通路中。最后,没有一个病例显示明显的拷贝数变化,肿瘤突变负担低,微卫星稳定。

相似文献

1
Comprehensive genetic profiling of six pulmonary nuclear protein in testis carcinomas with a novel micropapillary histological subtype in two cases.两例具有新型微乳头状组织学亚型的肺神经内分泌癌中六种核蛋白的综合基因谱分析。
Hum Pathol. 2021 Sep;115:56-66. doi: 10.1016/j.humpath.2021.02.004. Epub 2021 Mar 10.
2
NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion.腮腺 NUT 癌:两例报告,其中一例罕见的 ZNF532-NUTM1 融合。
Virchows Arch. 2022 Apr;480(4):887-897. doi: 10.1007/s00428-021-03253-9. Epub 2022 Jan 22.
3
Misleading Germ Cell Phenotype in Pulmonary NUT Carcinoma Harboring the ZNF532-NUTM1 Fusion.肺 NUT 癌中 ZNF532-NUTM1 融合导致的误导性生殖细胞表型。
Am J Surg Pathol. 2022 Feb 1;46(2):281-288. doi: 10.1097/PAS.0000000000001774.
4
Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production.甲状腺癌伴 NSD3::NUTM1 融合:具有甲状腺细胞分化和胶体产生的病例。
Endocr Pathol. 2022 Jun;33(2):315-326. doi: 10.1007/s12022-021-09700-2. Epub 2022 Jan 8.
5
BRD3-NUTM1-expressing NUT carcinoma of lung on endobronchial ultrasound-guided transbronchial needle aspiration cytology, a diagnostic pitfall.经支气管超声引导经支气管针吸活检术(EBUS-TBNA)细胞学检查中,BRD3-NUTM1 表达的肺 NUT 癌:一个诊断陷阱。
Diagn Cytopathol. 2022 Feb;50(2):E47-E53. doi: 10.1002/dc.24885. Epub 2021 Oct 21.
6
NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas.涎腺 NUT 癌:3 例临床病理和分子分析及涎腺癌中 NUT 表达的调查。
Am J Surg Pathol. 2018 Jul;42(7):877-884. doi: 10.1097/PAS.0000000000001046.
7
Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case.肺 NUT 癌的临床和分子特征表现出对免疫治疗的多样化反应,其中包括一例病理完全缓解病例。
J Cancer Res Clin Oncol. 2023 Aug;149(9):6361-6370. doi: 10.1007/s00432-023-04621-5. Epub 2023 Feb 8.
8
Clinicopathological molecular characterizations of sinonasal NUT carcinoma: a report of two cases and a literature review.鼻窦 NUT 癌的临床病理分子特征:两例报告及文献复习
Front Oncol. 2024 Jan 4;13:1296862. doi: 10.3389/fonc.2023.1296862. eCollection 2023.
9
NSD3-NUT-expressing midline carcinoma of the lung: first characterization of primary cancer tissue.表达NSD3-NUT的肺中线癌:原发性癌组织的首次特征描述。
Pathol Res Pract. 2015 May;211(5):404-8. doi: 10.1016/j.prp.2014.10.013. Epub 2014 Nov 13.
10
Expression of P16 in NUT carcinomas with no association with human papillomavirus (HPV).P16在与人类乳头瘤病毒(HPV)无关的NUT癌中的表达。
Appl Immunohistochem Mol Morphol. 2014 Apr;22(4):262-5. doi: 10.1097/PAI.0b013e3182a4ef2e.

引用本文的文献

1
Anti-angiogenic therapy as a beacon of hope in the battle against pulmonary NUT midline carcinoma.抗血管生成疗法是对抗肺NUT中线癌斗争中的希望之光。
Front Med. 2025 Jun 14. doi: 10.1007/s11684-025-1145-3.
2
NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions.NSD3 在癌症中的作用:揭示甲基转移酶依赖性和异构体特异性功能。
Int J Mol Sci. 2024 Jan 12;25(2):944. doi: 10.3390/ijms25020944.
3
Targeted therapy for rare lung cancers: Status, challenges, and prospects.罕见肺癌的靶向治疗:现状、挑战与展望。
Mol Ther. 2023 Jul 5;31(7):1960-1978. doi: 10.1016/j.ymthe.2023.05.007. Epub 2023 May 13.
4
Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case.肺 NUT 癌的临床和分子特征表现出对免疫治疗的多样化反应,其中包括一例病理完全缓解病例。
J Cancer Res Clin Oncol. 2023 Aug;149(9):6361-6370. doi: 10.1007/s00432-023-04621-5. Epub 2023 Feb 8.
5
Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production.甲状腺癌伴 NSD3::NUTM1 融合:具有甲状腺细胞分化和胶体产生的病例。
Endocr Pathol. 2022 Jun;33(2):315-326. doi: 10.1007/s12022-021-09700-2. Epub 2022 Jan 8.
6
Diagnosis of NUT Carcinoma Despite False-Negative Next-Generation Sequencing Results: A Case Report and Literature Review.尽管二代测序结果为假阴性,但仍确诊为NUT癌:一例报告及文献综述
Onco Targets Ther. 2021 Aug 27;14:4621-4633. doi: 10.2147/OTT.S327722. eCollection 2021.